Navigation überspringen
Universitätsbibliothek Heidelberg
Status: Bibliographieeintrag

Verfügbarkeit
Standort: ---
Exemplare: ---
heiBIB
 Online-Ressource
Verfasst von:Kis, Bernhard [VerfasserIn]   i
 Lücke, Caroline [VerfasserIn]   i
 Abdel-Hamid, Mona [VerfasserIn]   i
 Heßmann, Philipp [VerfasserIn]   i
 Graf, Erika [VerfasserIn]   i
 Berger, Mathias [VerfasserIn]   i
 Matthies, Swantje [VerfasserIn]   i
 Borel, Patricia [VerfasserIn]   i
 Sobanski, Esther [VerfasserIn]   i
 Alm, Barbara [VerfasserIn]   i
 Rösler, Michael [VerfasserIn]   i
 Retz, Wolfgang [VerfasserIn]   i
 Jacob, Christian [VerfasserIn]   i
 Colla, Michael [VerfasserIn]   i
 Huss, Michael [VerfasserIn]   i
 Jans, Thomas [VerfasserIn]   i
 Elst, Ludger Tebartz van [VerfasserIn]   i
 Müller, Helge H. O. [VerfasserIn]   i
 Philipsen, Alexandra [VerfasserIn]   i
Titel:Safety profile of Methylphenidate under long-term treatment in Adult ADHD patients$cresults of the COMPAS Study
Verf.angabe:Bernhard Kis, Caroline Lücke, Mona Abdel-Hamid, Philipp Heßmann, Erika Graf, Mathias Berger, Swantje Matthies, Patricia Borel, Esther Sobanski, Barbara Alm, Michael Rösler, Wolfgang Retz, Christian Jacob, Michael Colla, Michael Huss, Thomas Jans, Ludger Tebartz van Elst, Helge H.O. Müller, Alexandra Philipsen
E-Jahr:2020
Jahr:05.10.2020
Umfang:9 S.
Fussnoten:Gesehen am 17.03.2025
Titel Quelle:Enthalten in: Pharmacopsychiatry
Ort Quelle:Stuttgart [u.a.] : Thieme, 1984
Jahr Quelle:2020
Band/Heft Quelle:53(2020), 06, Seite 263-271
ISSN Quelle:1439-0795
Abstract:<p> <b>Introduction</b> The Comparison of Methylphenidate and Psychotherapy in adult ADHD Study (COMPAS) was a prospective, randomized multicenter clinical trial, comparing methylphenidate (MPH) with placebo (PLAC) in combination with cognitive behavioral group psychotherapy (GPT) or individual clinical management (CM) over the period of 1 year. Here, we report results on treatment safety.</p> <p> <b>Methods</b> MPH and PLAC were flexibly dosed. Among 433 randomized patients, adverse events (AEs) were documented and analyzed on an “as received” basis during week 0-52. Electrocardiogram data were recorded at baseline and week 24.</p> <p> <b>Results</b> Comparing 205 patients who received ≥1 dose of MPH with 209 patients who received PLAC, AEs occurring significantly more frequently in the MPH group were decreased appetite (22 vs. 3.8%), dry mouth (15 vs. 4.8%), palpitations (13 vs. 3.3%), gastrointestinal infection (11 vs. 4.8%), agitation (11 vs. 3.3%), restlessness (10 vs. 2.9%), hyperhidrosis, tachycardia, weight decrease (all 6.3 vs. 1.9%), depressive symptom, influenza (both 4.9 vs. 1.0%), and acute tonsillitis (4.4 vs. 0.5%). Syncope occurred significantly more often in the PLAC group (2.4 vs. 0%). Clinically relevant ECG changes occurred very rarely in both groups. Serious AEs were rare and without a significant group difference. The comparison of 206 patients treated with GPT versus 209 patients who received CM revealed no major differences. Serious AE classified as psychiatric occurred in 5 cases in the CM group and in 1 case in the GPT group.</p> <p> <b>Conclusion</b> In this so far longest-running clinical trial, methylphenidate treatment was safe and well-tolerated.</p>
DOI:doi:10.1055/a-1207-9851
URL:Bitte beachten Sie: Dies ist ein Bibliographieeintrag. Ein Volltextzugriff für Mitglieder der Universität besteht hier nur, falls für die entsprechende Zeitschrift/den entsprechenden Sammelband ein Abonnement besteht oder es sich um einen OpenAccess-Titel handelt.

Volltext: https://doi.org/10.1055/a-1207-9851
 Volltext: http://www.thieme-connect.de/DOI/DOI?10.1055/a-1207-9851
 DOI: https://doi.org/10.1055/a-1207-9851
Datenträger:Online-Ressource
Sprache:eng
K10plus-PPN:1919923225
Verknüpfungen:→ Zeitschrift

Permanenter Link auf diesen Titel (bookmarkfähig):  https://katalog.ub.uni-heidelberg.de/titel/69319291   QR-Code
zum Seitenanfang